Lipella Pharmaceuticals (LIPO) to Release Quarterly Earnings on Tuesday

Lipella Pharmaceuticals (NASDAQ:LIPO) is expected to be posting its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Lipella Pharmaceuticals to post earnings of ($2.43) per share for the quarter.

Lipella Pharmaceuticals Price Performance

LIPO opened at $2.93 on Friday. The stock has a market capitalization of $3.54 million, a price-to-earnings ratio of -0.69 and a beta of 0.28. The business has a 50-day moving average of $3.16 and a two-hundred day moving average of $3.17. Lipella Pharmaceuticals has a 12 month low of $2.21 and a 12 month high of $12.00.

About Lipella Pharmaceuticals

Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).